Shadowfetch

Section

Health

Medicine, public health, and the systems that pay for care — including where the sides disagree about the cure.

Testosterone labels shift after FDA safety review
CenterShadowfetch

Testosterone labels shift after FDA safety review

The answer-first version: the FDA has now updated its public testosterone guidance after a safety review found no meaningful difference in major cardiovascular events in a large…

Leah Marin Castellano · · 4 min read

CDC STI data show progress, but testing gaps still matter
CenterShadowfetch

CDC STI data show progress, but testing gaps still matter

The short version: the newest national STI numbers look better than they did a year earlier, but they are not a victory lap. CDC’s provisional 2024 surveillance data show reported…

Leah Marin Castellano · · 4 min read

FDA menopause label changes make the fine print matter
CenterShadowfetch

FDA menopause label changes make the fine print matter

The FDA has now approved the first six menopausal hormone therapy label updates after moving to remove boxed-warning language about cardiovascular…

Leah Marin Castellano · · 4 min read

Bicillin shortage puts syphilis prevention back in focus
CenterShadowfetch

Bicillin shortage puts syphilis prevention back in focus

The U.S. supply problem around Bicillin L-A, the first-line penicillin shot used for syphilis, is not over. CDC’s latest product-availability page says…

Leah Marin Castellano · · 4 min read